{"name":"Betaliq, Inc.","slug":"betaliq-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQbk91SWw5cmEtMzhiRXhJNmRsVnpBaWhfcXg0T0h5Szh4Tm1zSGk0V1h1emxUcVRmaVgyczdpM1ZXXzJFYVBvWXRuNGpXckd1NjJzWmU0ZVFNMmpJSFl6dTFDR0I3Zzk0VURWZmo0bGl1Zl9hbHhOY1k3elhSNXlXM09HeDlMNk5mSFlZajQxSDctOGl5c0ZtYm9fbnZ6aEU?oc=5","date":"2026-04-03","type":"earnings","source":"openPR.com","summary":"Open Angle Glaucoma Market: Expanding Revenue Landscape to 2034 - openPR.com","headline":"Open Angle Glaucoma Market: Expanding Revenue Landscape to 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxOTlQzRkpQQlZDZXVlTFU3RzJWVV9HN3RhdWxyQ1gxdGJDaHFvZWpFQy1tOWRDbXhESDk2RkVWajdQZ2NhSTFncGlxTF9WTEVXMTdYZlhWdmd6NVI3b1FTbGdCZjNGTXBrVWp3S19GUF9DZlh0OFF3RXI0cU1XMFZhVXFzZjJZVkNpUU95bm9Jc0Y3Sm9yMkFoQ1dTTzNPb29PY0MwZ2VWaXJNR3d0WHgtY1BXV0FFWlMzZFRwdGl6VmR5U2xGMUNSLTRLdm9UQ2p6dVlvYU1BemYySTVLTE5va3ZFdmxvb0thRXNUNzlCVWJld0VuUDZn?oc=5","date":"2025-09-09","type":"pipeline","source":"PR Newswire","summary":"Open-Angle Glaucoma Market Outlook Brightens as Emerging Therapies Reshape Treatment Paradigms | DelveInsight - PR Newswire","headline":"Open-Angle Glaucoma Market Outlook Brightens as Emerging Therapies Reshape Treatment Paradigms | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxORGQzbUxJS05QcFpUZ2lsZnBBdnl3M0QzLW1SVlc2Wi1Ca3NKTnBUUFRicFBCUzNzQ0t2cUE5OTUyX3hsN2Z2aHlPOFJhanVBUWpZYjlDa1UtRm9TZmE0NWg4c1VFUlNGb3hxQkxRcHpQcXNoVzFjdGprNzlZYlJ2S3BpakRsVy1QMFJLZ3lmWVM?oc=5","date":"2025-06-06","type":"trial","source":"endpoints.news","summary":"At a crossroads, biotechs are passing on reverse mergers in 2025 - endpoints.news","headline":"At a crossroads, biotechs are passing on reverse mergers in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wJBVV95cUxPODdndklCZ0RXOUh3S0hTOUVBa2tBQTE0dmFDY1lQbnBVLU9MdkZ6VVNUb2VKVE9qaVl6OFlDNjVpb0drRml3eGFJR1FfSXYxeHZ4MWdBYTNrYy05OXdPUFRtd2dkbE5BUUk1NDVteFRUaGVhbDhoaEo5MlRSUVA1bk9DMVRiNkhwbXNwZkRlMWhDX0dBbVppNWVrdzU3MEg1RDZtZHdhM0gzYmI4SFNjclI3OW5PYldIcjlGU2ctV2NNSzNpRm5sYkdabUt1OE42X0VSbWR5SDJBRlJfazk0T09hUmxqdFhfZjJta2czbTBqbFRadmxQbU4zUkRybEVKcVd4b01wTGJ0OWxtM0lSYUx5UVpOOElHWm8xb2tTdDdJbkdUQUNnYlI5TVhtNkg5M1Q3aUVSS2VYSGk3Xy1Xblh6b0syaHlGUzdaZGZ2YlQ0R1U?oc=5","date":"2025-05-19","type":"deal","source":"GlobeNewswire","summary":"Eyenovia Provides Updates on Potential Merger with Betaliq - GlobeNewswire","headline":"Eyenovia Provides Updates on Potential Merger with Betaliq","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQMDhMdU9EeDlVcFRMRlVDa1FaaUo4RkFKekpySFdodEZHUnoydVJrSVFNTGNNZzg0Rnp4X2g1TXBoWDJIOHA5aDFPU0lpOGM1SnRNd3pITU1zNUhCckpBQlJGVHF2NzhUR3VUVE5jMG83UVhKc2U5WHg4SURiV3JYMzc2REJJSXhRZ0hmUUhSbHhQcmdtTHVXYmQ4UUZuMTE1TjNKNGJVQ1dJN21kRWdFTEVGOC1zUQ?oc=5","date":"2025-03-28","type":"deal","source":"Eyes On Eyecare","summary":"Eyenovia proposes merger with Betaliq to form glaucoma company - Eyes On Eyecare","headline":"Eyenovia proposes merger with Betaliq to form glaucoma company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPNmZQWHBydHdBS1FBdks5c1Azc19qZ0tQV3FENVhfUmRDSVo4LU01R09seTlxYlFiSTlrV2N1akZMdWI2Yk5FeS01OC1vR2tzMjE4WnJYcUJfOEFOdkFNWGFrc3diY05uVkI0Vkszd1NheFA2eHJ5alVXT1pEOGNzSlBCb195a1ZmY2JxZl9XTDZrb29MZnFxbg?oc=5","date":"2025-03-26","type":"deal","source":"Optometry Times","summary":"Eyenovia, Betaliq enter potential reverse merger agreement - Optometry Times","headline":"Eyenovia, Betaliq enter potential reverse merger agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTFB4Y3Q5TmIzeUFZZEdabnFfX3l3MmtrV3J3MmN4WExJdkNVOGRBY1oxb1ZGQ0dtRHV3bFpRWkd2dVVfejkyNHp4QVhFazlIX1M1b0dYNW40a1ZZT0hpOWxSMU81RDhlVjA0NUFoSHAzUWJwLXNsQ1NxRnd2SQ?oc=5","date":"2019-04-30","type":"pipeline","source":"BioSpace","summary":"Betaliq Launches in Tampa to Focus on Glaucoma - BioSpace","headline":"Betaliq Launches in Tampa to Focus on Glaucoma","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}